273 related articles for article (PubMed ID: 25808050)
1. Clinical and quality evaluation of apheresis vs random-donor platelet concentrates stored for 7 days.
Hussein E
Transfus Med; 2015 Feb; 25(1):20-6. PubMed ID: 25808050
[TBL] [Abstract][Full Text] [Related]
2. Platelet function testing during 5-day storage of single and random donor plateletpheresis.
Akay OM; Gündüz E; Başyiğit H; Gulbas Z
Transfus Apher Sci; 2007 Jun; 36(3):285-9. PubMed ID: 17602871
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-yield thrombocytapheresis on the quality of platelet products.
Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
5. Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.
Tynngård N; Boknäs N; Trinks M; Dreimane A; Berlin G
Transfusion; 2019 Feb; 59(2):723-728. PubMed ID: 30548486
[TBL] [Abstract][Full Text] [Related]
6. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
Sloand EM; Yu M; Klein HG
Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
8. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of store lesion in platelet obtained by apheresis compared to platelet derived from whole blood and its impact on the in vitro functionality.
Quintero M; Núñez M; Mellado S; Maldonado M; Wehinger S
Transfus Apher Sci; 2015 Dec; 53(3):293-9. PubMed ID: 26043812
[TBL] [Abstract][Full Text] [Related]
11. A critical comparison of platelet preparation methods.
Vassallo RR; Murphy S
Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
13. Era of blood component therapy: time for mandatory pre-donation platelet count for maximizing donor safety and optimizing quality of platelets.
Das SS; Zaman RU; Biswas D
Transfus Apher Sci; 2013 Dec; 49(3):640-3. PubMed ID: 23928130
[TBL] [Abstract][Full Text] [Related]
14. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
O'Rafferty C; Rooney G; Hagan R; Woolfson M; O'Donghaile D; Fitzgerald J
Transfus Med; 2017 Oct; 27 Suppl 5():369-374. PubMed ID: 28393455
[TBL] [Abstract][Full Text] [Related]
15. Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicine.
Winkler AM; Sheppard CA; Culler EE; Myers RL; Duncan A; Castillejo MI; Hillyer CD; Josephson CD
Transfusion; 2010 Oct; 50(10):2193-8. PubMed ID: 20456709
[TBL] [Abstract][Full Text] [Related]
16. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
17. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
Posch U; Kokelj M; Kostner GM; Lanzer G
Beitr Infusionsther Transfusionsmed; 1994; 32():78-80. PubMed ID: 9480162
[TBL] [Abstract][Full Text] [Related]
18. Extended storage of single-donor apheresis platelets in CLX blood bags: effect of storage on platelet morphology, viability and in vitro function.
Kenney DM; Peterson JJ; Smith JW
Vox Sang; 1988; 54(1):24-33. PubMed ID: 3348019
[TBL] [Abstract][Full Text] [Related]
19. Seven-day storage of apheresis platelets: report of an in vitro study.
Dumont LJ; VandenBroeke T
Transfusion; 2003 Feb; 43(2):143-50. PubMed ID: 12559008
[TBL] [Abstract][Full Text] [Related]
20. Freezing of Apheresis Platelet Concentrates in 6% Dimethyl Sulfoxide: The First Preliminary Study in Turkey.
Yılmaz S; Çetinkaya RA; Eker İ; Ünlü A; Uyanık M; Tapan S; Pekoğlu A; Pekel A; Erkmen B; Muşabak U; Yılmaz S; Avcı İY; Avcu F; Kürekçi E; Eyigün CP
Turk J Haematol; 2016 Mar; 33(1):28-33. PubMed ID: 25912150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
